| Financial Year |
March 31 2023 |
| Monetary Funds |
11,686,704,809.67 |
| Held-for-trading Financial Assets |
1,890,358,484.97 |
| Notes Receivable |
457,778,828.43 |
| Accounts Receivable |
2,869,999,398.29 |
| Advances to Suppliers |
1,428,243,283.61 |
| Other Receivables |
190,489,783.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,694,864,325.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
146,618,929.26 |
| Other Current Assets |
1,336,991,302.01 |
| Total Current Assets |
31,678,296,456.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
82,487,819.30 |
| Long-term Equity Investment |
550,285,925.15 |
| Investment Properties |
6,869,896.23 |
| Fixed Assetes |
27,376,185,029.86 |
| Under-construction Projects |
6,030,883,939.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,001,506,340.62 |
| R&D expenses |
-- |
| Goodwill |
1,762,836,435.77 |
| Long-Term Deferred and Prepaid Expenses |
17,452,125.45 |
| Deferred Income Tax Assets |
672,788,830.27 |
| Other Non-Current Assets |
1,259,667,736.08 |
| Sub-Total of Non-Current Assets |
45,079,060,246.73 |
| Total Assets |
76,757,356,703.35 |
| Short-Term Loans |
12,832,382,104.49 |
| Trading Financial liabilities |
5,106,900.00 |
| Notes Payable |
8,060,031,589.49 |
| Accounts Payable |
6,288,718,549.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
661,663,232.20 |
| Taxes Payable |
196,552,756.78 |
| Interest Payable |
-- |
| Dividend Payable |
12,610,627.61 |
| Other payables |
799,122,124.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,205,971,231.08 |
| Other Current Liabilities |
1,072,486,992.28 |
| Sub-Total of Current Liabilities |
35,818,026,515.09 |
| Long-term Loans |
7,112,674,141.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
737,956,799.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
538,588,460.74 |
| Deferred Income Tax Liabilities |
558,408,873.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,876,061,000.76 |
| Total Liabilities |
45,694,087,515.85 |
| Paid-In Capital(Or Share Stock) |
6,165,091,011.00 |
| Capital Surplus |
4,680,404,316.41 |
| Surplus Reserve |
1,624,243,649.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,743,127,361.72 |
| Minority Stockholder's Interest |
4,730,561,979.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,332,707,208.23 |
| Owner's Equity（Stockholder's Equity） |
31,063,269,187.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
76,757,356,703.34 |
